BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 6749707)

  • 1. BCG vaccination in leprosy.
    Price JE
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of leprosy in relation to control. Report of a WHO Study Group.
    World Health Organ Tech Rep Ser; 1985; 716():1-60. PubMed ID: 3925646
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
    Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G
    Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
    Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
    Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control.
    Pallen MJ
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune status of subsided cases of tuberculoid (TT) and borderline tuberculoid (BT) leprosy.
    Mackay IG; Sengupta U; Ghei SK; Sinha S; Ramu G
    Lepr India; 1982 Oct; 54(4):653-63. PubMed ID: 6763967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of leprosy patients and healthy contacts.
    Samuel NM; Neupani K; Loudon J; Samuel S
    Indian J Lepr; 1985; 57(2):288-96. PubMed ID: 3908576
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects for chemotherapy of leprosy.
    Ji B
    Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed lepromin reaction and BCG application in first grade school children in S. Paulo, Brazil.
    Barbieri TA; Correa WM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):750-5. PubMed ID: 4948223
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J; Ulrich M
    Indian J Lepr; 2000; 72(1):21-32. PubMed ID: 10935184
    [No Abstract]   [Full Text] [Related]  

  • 16. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
    Shetty VP; Mistry NF; Wakade AV; Ghate SD; Capadia GD; Pai VV
    Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy and tuberculosis: a comparative study with the aid of skin tests with tuberculin, killed BCG, and the Dharmendra lepromin in South African Bantus.
    KOOIJ R; RUTGERS AW
    Int J Lepr; 1958; 26(1):24-40. PubMed ID: 13586953
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine trials in leprosy--Venezuela, Malawi and India.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S32-7. PubMed ID: 10700935
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy vaccine--a puzzle.
    Job CK
    Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.